Show simple item record

dc.contributor.authorBelspo
dc.date2013
dc.date.accessioned2016-06-13T11:35:58Z
dc.date.available2016-06-13T11:35:58Z
dc.identifier.urihttps://orfeo.kbr.be/handle/internal/4178
dc.descriptionresponse to the emerging opiate use, opiate substitution treatment (OST) first appeared in the EU in the late 1960s (EMCDDA, 2000). Several international studies show that OST treatment is effective in reducing crime (Schwarts et al., 2009), reducing risks (Keen, Oliver, Rowse, & Mathers, 2003), reducing morbidity and mortality (Moller, Karymbaeva, Subata, Kiaer, 2009) reducing heroin use (Amato, Davolia, Peruccia, Ferria, Faggiano, & Mattick, 2005), reducing the use of other illegal drugs (Masson et al., 2004), increasing treatment retention (Amato et al., 2005) and increasing quality of life regarding employment, housing status and education (Vanagas, Padaiga, & Bagdonas, 2010).
dc.languageeng
dc.publisherBrussels : Federal Science Policy, 2013
dc.titleAnalysis and optimization of substitution treatment in Belgium. Conclusions and recommendations : summary
dc.typeReport
dc.subject.frascatiHealth sciences
dc.subject.frascatiClinical medicine
dc.audiencePolicy-Oriented
dc.audienceScientific
dc.subject.freeHEALTH
Orfeo.peerreviewedNot pertinent
dc.identifier.belspoSP2562
dc.relation.belspo-projectDR/58


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record